Microrna Biomarker Identification for Pediatric Acute Myeloid Leukemia Based on A Novel Bioinformatics Model

Wenying Yan,Lihua Xu,Zhandong Sun,Yuxin Lin,Wenyu Zhang,Jiajia Chen,Shaoyan Hu,Bairong Shen
DOI: https://doi.org/10.18632/oncotarget.4459
2015-01-01
Oncotarget
Abstract:Acute myeloid leukemia (AML) in children is a complex and heterogeneous disease. The identification of reliable and stable molecular biomarkers for diagnosis, especially early diagnosis, remains a significant therapeutic challenge. Aberrant microRNA expression could be used for cancer diagnosis and treatment selection. Here, we describe a novel bioinformatics model for the prediction of microRNA biomarkers for the diagnosis of paediatric AML based on computational functional analysis of the microRNA regulatory network substructure. microRNA-196b, microRNA-155 and microRNA-25 were identified as putative diagnostic biomarkers for pediatric AML. Further systematic analysis confirmed the association of the predicted microRNAs with the leukemogenesis of AML. In vitro q-PCR experiments showed that microRNA-155 is significantly overexpressed in children with AML and microRNA-196b is significantly overexpressed in subgroups M4-M5 of the French-American-British classification system. These results suggest that microRNA-155 is a potential diagnostic biomarker for all subgroups of paediatric AML, whereas microRNA-196b is specific for subgroups M4-M5.
What problem does this paper attempt to address?